. Author manuscript; available in PMC: 2025 Mar 1.

Published in final edited form as: Ann Child Neurol Soc. 2024 Jan 10;2(1):60–72. doi: 10.1002/cns3.20058

Table 3. Comparison between Treatment Groups and Sturge-Weber Extent.

		Standard Treatment Group		Presymptomatic Treatment Group
Sturge-Weber Extent	Extent of Involvement	n	%	n	%	P-value
Brain involvement	Unilateral	50	83.3	20	62.5	.026
Brain involvement	Bilateral	10	16.7	12	37.5	.026
Skin involvement	None	10	16.7	0	0	.004
	Unilateral	33	55.0	15	46.9
	Bilateral	17	28.3	17	53.1
Eye Involvement	None	31	51.7	16	50.0	.836
	Unilateral	19	31.7	10	31.3
	Bilateral	10	16.7	6	18.8
Total SWS involvement	1	10	16.7	0	0	.023
	2	16	26.7	9	28.1
	3	16	26.7	5	15.6
	4	10	16.7	13	40.6
	5	3	5.0	0	0
	6	5	8.3	5	15.6